Literature DB >> 8624994

Regulated analgesics and pain control.

N A Hagen, P Flynne, N Macdonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8624994      PMCID： PMC1487818     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  12 in total

1.  Do drug regulations affect medical practice?

Authors:  D E Weissman
Journal:  J Pain Symptom Manage       Date:  1992-07       Impact factor: 3.612

2.  Neuropathic pain.

Authors:  P D Wall
Journal:  Pain       Date:  1990-12       Impact factor: 6.961

3.  Long-term oral opioid therapy in patients with chronic nonmalignant pain.

Authors:  M Zenz; M Strumpf; M Tryba
Journal:  J Pain Symptom Manage       Date:  1992-02       Impact factor: 3.612

4.  Opioid pseudoaddiction--an iatrogenic syndrome.

Authors:  D E Weissman; J D Haddox
Journal:  Pain       Date:  1989-03       Impact factor: 6.961

5.  Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia.

Authors:  M C Rowbotham; L A Reisner-Keller; H L Fields
Journal:  Neurology       Date:  1991-07       Impact factor: 9.910

6.  Pain and its treatment in outpatients with metastatic cancer.

Authors:  C S Cleeland; R Gonin; A K Hatfield; J H Edmonson; R H Blum; J A Stewart; K J Pandya
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

7.  Diffusion of standards of care for cancer pain.

Authors:  N Hagen; J Young; N MacDonald
Journal:  CMAJ       Date:  1995-04-15       Impact factor: 8.262

8.  Liability issues in the management of pain.

Authors:  R S Shapiro
Journal:  J Pain Symptom Manage       Date:  1994-04       Impact factor: 3.612

9.  Chronic use of opioid analgesics in non-malignant pain: report of 38 cases.

Authors:  Russell K Portenoy; Kathleen M Foley
Journal:  Pain       Date:  1986-05       Impact factor: 6.961

Review 10.  Chronic opioid therapy in nonmalignant pain.

Authors:  R K Portenoy
Journal:  J Pain Symptom Manage       Date:  1990-02       Impact factor: 3.612
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.